Biotechnology; Pharmaceutical
Ayala Pharmaceuticals has raised €27M across 1 funding round from 1 investor, most recently a Series B round in Apr 2019. Based in Tel Aviv, Israel; founded 2017. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-04-01 | Series B |
| €27M |
| Novartis |
| View deal → |
